NCT03512756 2024-11-06
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Tyme, Inc
Phase 2/3 Terminated
Tyme, Inc
West China Hospital
Clovis Oncology, Inc.
The Netherlands Cancer Institute
The University of Texas Health Science Center at San Antonio